Researchers apply KPV to investigate its intracellular actions, including inhibition of NF-κB nuclear translocation and reduction of pro-inflammatory mediator release in colonic epithelial and immune cells. Pre-clinical observations in murine models demonstrate attenuated inflammatory infiltrates, preserved mucosal integrity, and PepT1-dependent uptake facilitating direct cellular effects.
This tripeptide supports detailed examination of anti-inflammatory mechanisms independent of melanocortin receptor activation in certain systems, with focus on mucosal tissue responses under inflammatory challenge.
Scientific Overview of KPV Applications
Pre-clinical models highlight KPV’s engagement with inflammatory signaling pathways:
- Inhibition of NF-κB activation and suppression of pro-inflammatory cytokine synthesis (TNF-α, IL-1β) in colonic epithelial cells and macrophages. https://pubmed.ncbi.nlm.nih.gov/18061177/
- PepT1-mediated intracellular uptake into intestinal epithelial cells, enabling direct modulation of inflammatory cascades in colitis models. https://pubmed.ncbi.nlm.nih.gov/18061177/
- Attenuation of colitis severity, reduced inflammatory infiltrates, and lowered MPO activity in DSS- and TNBS-induced murine IBD models following oral administration. https://pubmed.ncbi.nlm.nih.gov/18092346/
- Suppression of p65RelA nuclear import in airway epithelial cells, potentially via importin interactions in inflammatory respiratory models. https://pubmed.ncbi.nlm.nih.gov/22837805/
- Reduction of systemic and local inflammatory responses in peritonitis and mucosal challenge models, independent of MC1R in select contexts. https://pubmed.ncbi.nlm.nih.gov/12750433/
- Examination of targeted delivery enhancements (e.g., nanoparticle formulations) for improved mucosal anti-inflammatory efficacy in ulcerative colitis paradigms. https://pubmed.ncbi.nlm.nih.gov/28143741/
For additional context on short peptide anti-inflammatory mechanisms, mucosal immunology, and NF-κB signaling in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs KPV
National Science Labs manufactures KPV under stringent GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this peptide have not been evaluated by the FDA.
Initiate Your KPV Research Protocol
Source high-purity KPV from current limited batches to ensure optimal stability and performance in anti-inflammatory signaling and mucosal barrier studies.
